Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Q Meng

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|September 29, 2001
Ezetimibe (Schering-Plough)C Q Meng
Current Opinion in Investigational Drugs (London, England : 2000)|November 23, 2001
Restenosis drug discovery--a formidable taskC Q Meng
Bioorganic & Medicinal Chemistry Letters|June 15, 2000
5-Thienyltryptamine derivatives as serotonin 5-HT1B/1D receptor agonists: potential treatments for migraineC Q Meng, S Rakhit, D K Lee, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2001
Nitrobenzene compounds inhibit expression of VCAM-1C Q Meng, X S Zheng, L A Holt, et al.
Bioorganic & Medicinal Chemistry Letters|August 11, 2000
5-Alkyltryptamine derivatives as highly selective and potent 5-HT1D receptor agonistsA Slassi, L Edwards, A O'Brien, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Current Opinion in Investigational Drugs (London, England : 2000)|September 29, 2001
Ezetimibe (Schering-Plough)C Q Meng
Current Opinion in Investigational Drugs (London, England : 2000)|November 23, 2001
Restenosis drug discovery--a formidable taskC Q Meng
Bioorganic & Medicinal Chemistry Letters|June 15, 2000
5-Thienyltryptamine derivatives as serotonin 5-HT1B/1D receptor agonists: potential treatments for migraineC Q Meng, S Rakhit, D K Lee, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2001
Nitrobenzene compounds inhibit expression of VCAM-1C Q Meng, X S Zheng, L A Holt, et al.
Bioorganic & Medicinal Chemistry Letters|August 11, 2000
5-Alkyltryptamine derivatives as highly selective and potent 5-HT1D receptor agonistsA Slassi, L Edwards, A O'Brien, et al.
Pageof 1